Patents by Inventor David G. Klapper

David G. Klapper has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treating sensitivity to protein allergen using peptides which include a T cell epitope recognized by a T cell receptor specific for the protein allergen
    Patent number: 6335019
    Abstract: Antigen E or Amb a I of ragweed pollen has been shown to be a family or families of proteins. cDNAs encoding Amb a I, the major human allergen of ragweed and Amb a II, peptides derived from Amb a I or Amb a II, antibodies against the peptides; and methods of treating individuals for sensitivity to ragweed are disclosed.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: January 1, 2002
    Assignee: Immulogic Pharmaceutical Corp.
    Inventors: Bruce Rogers, David G. Klapper, Thorunn Rafnar, Mei-chang Kuo
  • Allergenic peptides from ragweed pollen
    Patent number: 6335020
    Abstract: Antigen E or Amb a I of ragweed pollen has been shown to be a family or families of proteins. cDNAs encoding Amb a I, the major human allergen of ragweed and Amb a II, peptides derived from Amb a I or Amb a II, antibodies against the peptides; and methods of treating individuals for sensitivity to ragweed are disclosed.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: January 1, 2002
    Assignee: Immulogic Pharmaceutical Corp.
    Inventors: Bruce Rogers, David G. Klapper, Thorunn Rafnar, Mei-chang Kuo
  • Nucleic acids encoding allergenic proteins from ragweed
    Patent number: 5776761
    Abstract: Antigen E or Amb a I of ragweed pollen has been shown to be a family or families of proteins. cDNAs encoding Amb a I, the major human allergen of ragweed and Amb a II, peptides derived from Amb a I or Amb a II, antibodies against the peptides; and methods of treating individuals for sensitivity to ragweed are disclosed.
    Type: Grant
    Filed: December 29, 1993
    Date of Patent: July 7, 1998
    Assignees: ImmuLogic Pharmaceutical Corporation, the University of North Carolina at Chapel Hill
    Inventors: Bruce Rogers, David G. Klapper, Thorunn Rafnar, Mei-chang Kuo
  • Recombinant allergenic proteins from ragweed pollen
    Patent number: 5698204
    Abstract: Antigen E or Amb a I of ragweed pollen has been shown to be a family or families of proteins. cDNAs encoding Amb a I, the major human allergen of ragweed and Amb a II, peptides derived from Amb a I or Amb a II, antibodies against the peptides; and methods of treating individuals for sensitivity to ragweed are disclosed.
    Type: Grant
    Filed: August 15, 1994
    Date of Patent: December 16, 1997
    Assignees: ImmuLogic Pharmaceutical Corporation, University of North Carolina at Chapel Hill
    Inventors: Bruce Rogers, David G. Klapper, Thorunn Rafnar, Mei-chang Kuo